ANI Pharmaceuticals | ANIP - صافي الدخل





صافي الدخل تغيير تاريخ
AbbVie USD 3.61B 2.92B 2026-06
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Aurora Cannabis CAD -71.1M 72.92M 2026-03
Canopy Growth CAD -157.11M 94.49M 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Hikma Pharmaceutical USD 164M 45M 2025-12
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Omeros USD -32.23M 23.81M 2024-09
Perrigo USD -398.6M 1.02B 2026-03
Sun Pharmaceuticals INR 28.95B 1.81B 2026-06
Teva Pharmaceutical Industries USD -576M 945M 2026-06